PEGylated carbon dot/MnO2 nanohybrid: a new pH/H2O2-driven, turn-on cancer nanotheranostics
Source abstract
Abstract
The effect of tumor-targeted photodynamic therapy (PDT) was improved by designing nanotheranostics to promote oxygenation in a tumor microenvironment (TME) wherein hypoxia, acidosis, and the elevated levels of H2O2 are three main characteristics. In this study, a carbon dot (CD) PDT agent recently developed by our group was firstly applied as reducing agent to react with potassium permanganate for fabricating CDs/manganese dioxide (CDs/MnO2) composites, which were in turn modified with polyethylene glycol (PEG) to form water-soluble CDs/MnO2-PEG nanohybrids. In a normal physiological environment, the as-prepared nanohybrids exhibited quenched fluorescence, weak singlet oxygen generation, and low magnetic resonance imaging (MRI) signal. However, given the high sensitivity of MnO2 to the TME, the CDs/MnO2-PEG nanohybrids changed from an “off” to an “on” state with synchronously enhanced fluorescence, singlet oxygen generation, and MRI signal in the TME. In vitro and in vivo analyses have revealed that CDs/MnO2-PEG nanohybrids could be applied as TME-driven, turn-on nanotheranostics for the MR/fluorescence bimodal imaging-guided PDT of cancer. Moreover, complete clearance of CDs/MnO2-PEG nanohybrids from the body of mice was observed, indicating their low long-term toxicity and good biocompatibility. This work offers a new nanotheranostic candidate for modulating the unfavorable TME, particularly for the targeted PDT of cancer through precise positioning and oxygen generation.
Source: openaire · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Nanoplatforms for cancer theranostics · Carbon and Quantum Dots Applications · Luminescence and Fluorescent Materials
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (62)
Show source-provided references
1. Kunjachan S, Ehling J, Storm G, et al. Noninvasive imaging of nanomedicines and nanotheranostics: principles, progress, and prospects. Chem Rev, 2015, 115: 10907–1093710.1021/cr500314d ↗
2. Sun Q, Sun X, Ma X, et al. Integration of nanoassembly functions for an effective delivery cascade for cancer drugs. Adv Mater, 2014, 26: 7615–762110.1002/adma.201401554 ↗
3. Singh RK, Patel KD, Leong KW, et al. Progress in nanotheranostics based on mesoporous silica nanomaterial platforms. ACS Appl Mater Interfaces, 2017, 9: 10309–1033710.1021/acsami.6b16505 ↗
4. Huang H, Lovell JF. Advanced functional nanomaterials for theranostics. Adv Funct Mater, 2017, 27: 160352410.1002/adfm.201603524 ↗
5. Huo M, Wang L, Chen Y, et al. Tumor-selective catalytic nanomedicine by nanocatalyst delivery. Nat Commun, 2017, 8: 35710.1038/s41467-017-00424-8 ↗
6. Shi J, Kantoff PW, Wooster R, et al. Cancer nanomedicine: progress, challenges and opportunities. Nat Rev Cancer, 2017, 17: 20–3710.1038/nrc.2016.108 ↗
7. Anchordoquy TJ, Barenholz Y, Boraschi D, et al. Mechanisms and barriers in cancer nanomedicine: addressing challenges, looking for solutions. ACS Nano, 2017, 11: 12–1810.1021/acsnano.6b08244 ↗
8. Ma Y, Li X, Li A, et al. H2S-activable MOF nanoparticle photosensitizer for effective photodynamic therapy against cancer with controllable singlet-oxygen release. Angew Chem Int Ed, 2017, 56: 13752–1375610.1002/anie.201708005 ↗
9. Hu D, Sheng Z, Gao G, et al. Activatable albumin-photosensitizer nanoassemblies for triple-modal imaging and thermal-modulated photodynamic therapy of cancer. Biomaterials, 2016, 93: 10–1910.1016/j.biomaterials.2016.03.037 ↗
10. Luo D, Carter KA, Razi A, et al. Doxorubicin encapsulated in stealth liposomes conferred with light-triggered drug release. Biomaterials, 2016, 75: 193–20210.1016/j.biomaterials.2015.10.027 ↗
11. Lucky SS, Soo KC, Zhang Y. Nanoparticles in photodynamic therapy. Chem Rev, 2015, 115: 1990–204210.1021/cr5004198 ↗
12. Yuan Y, Zhang CJ, Gao M, et al. Specific light-up bioprobe with aggregation-induced emission and activatable photoactivity for the targeted and image-guided photodynamic ablation of cancer cells. Angew Chem Int Ed, 2015, 54: 1780–178610.1002/anie.201408476 ↗
13. Guo L, Liu W, Niu G, et al. Polymer nanoparticles with high photothermal conversion efficiency as robust photoacoustic and thermal theranostics. J Mater Chem B, 2017, 5: 2832–283910.1039/C7TB00498B ↗
14. Xing R, Liu K, Jiao T, et al. An injectable self-assembling collagengold hybrid hydrogel for combinatorial antitumor photothermal/photodynamic therapy. Adv Mater, 2016, 28: 3669–367610.1002/adma.201600284 ↗
15. Jia Q, Chen M, Liu Q, et al. Ethylene glycol-mediated synthetic route for production of luminescent silicon nanorod as photodynamic therapy agent. Sci China Mater, 2017, 60: 881–89110.1007/s40843-017-9101-5 ↗
16. Wen R, Lv X, Yang T, et al. Albumin nanoreactor-templated synthesis of Gd2O3/CuS hybrid nanodots for cancer theranostics. Sci China Mater, 2017, 60: 554–56210.1007/s40843-017-9056-1 ↗
17. Yu Z, Wang M, Pan W, et al. Tumor microenvironment-triggered fabrication of gold nanomachines for tumor-specific photoacoustic imaging and photothermal therapy. Chem Sci, 2017, 8: 4896–490310.1039/C7SC00700K ↗
18. Kanamala M, Wilson WR, Yang M, et al. Mechanisms and biomaterials in pH-responsive tumour targeted drug delivery: a review. Biomaterials, 2016, 85: 152–16710.1016/j.biomaterials.2016.01.061 ↗
19. Mura S, Nicolas J, Couvreur P. Stimuli-responsive nanocarriers for drug delivery. Nat Mater, 2013, 12: 991–100310.1038/nmat3776 ↗
20. Mou J, Chen Y, Ma M, et al. Facile synthesis of liposome/Cu2−xSbased nanocomposite for multimodal imaging and photothermal therapy. Sci China Mater, 2015, 58: 294–30110.1007/s40843-015-0044-3 ↗
21. Mathiyazhakan M, Upputuri PK, Sivasubramanian K, et al. In situ synthesis of gold nanostars within liposomes for controlled drug release and photoacoustic imaging. Sci China Mater, 2016, 59: 892–90010.1007/s40843-016-5101-3 ↗
22. Dai Y, Xu C, Sun X, et al. Nanoparticle design strategies for enhanced anticancer therapy by exploiting the tumour microenvironment. Chem Soc Rev, 2017, 46: 3830–385210.1039/C6CS00592F ↗
23. Khawar IA, Kim JH, Kuh HJ. Improving drug delivery to solid tumors: Priming the tumor microenvironment. J Control Release, 2015, 201: 78–8910.1016/j.jconrel.2014.12.018 ↗
24. Wu T, Dai Y. Tumor microenvironment and therapeutic response. Cancer Lett, 2016, 387: 61–6810.1016/j.canlet.2016.01.043 ↗
25. Cheng H, Zhu JY, Li SY, et al. An O2 self-sufficient biomimetic nanoplatform for highly specific and efficient photodynamic therapy. Adv Funct Mater, 2016, 26: 7847–786010.1002/adfm.201603212 ↗
26. Chen H, Tian J, He W, et al. H2O2-activatable and O2-evolving nanoparticles for highly efficient and selective photodynamic therapy against hypoxic tumor cells. J Am Chem Soc, 2015, 137: 1539–154710.1021/ja511420n ↗
27. Chen Q, Feng L, Liu J, et al. Intelligent albumin-MnO2 nanoparticles as pH-/H2O2-responsive dissociable nanocarriers to modulate tumor hypoxia for effective combination therapy. Adv Mater, 2016, 28: 7129–713610.1002/adma.201601902 ↗
28. Yang G, Zhang R, Liang C, et al. Manganese dioxide coated WS2@Fe3O4/sSiO2 nanocomposites for pH-responsive MR imaging and oxygen-elevated synergetic therapy. Small, 2018, 14: 170266410.1002/smll.201702664 ↗
29. Liu J, Chen Q, Zhu W, et al. Nanoscale-coordination-polymershelled manganese dioxide composite nanoparticles: a multistage redox/pH/H2O2-responsive cancer theranostic nanoplatform. Adv Funct Mater, 2017, 27: 160592610.1002/adfm.201605926 ↗
30. Yuan F, Li S, Fan Z, et al. Shining carbon dots: Synthesis and biomedical and optoelectronic applications. Nano Today, 2016, 11: 565–58610.1016/j.nantod.2016.08.006 ↗
31. Lim SY, Shen W, Gao Z. Carbon quantum dots and their applications. Chem Soc Rev, 2015, 44: 362–38110.1039/C4CS00269E ↗
32. Zhu S, Meng Q, Wang L, et al. Highly photoluminescent carbon dots for multicolor patterning, sensors, and bioimaging. Angew Chem Int Ed, 2013, 52: 3953–395710.1002/anie.201300519 ↗
33. Chen Y, Shi J. Mesoporous carbon biomaterials. Sci China Mater, 2015, 58: 241–25710.1007/s40843-015-0037-2 ↗
34. Roy E, Patra S, Madhuri R, et al. Carbon dot/TAT peptide coconjugated bubble nanoliposome for multicolor cell imaging, nuclear-targeted delivery, and chemo/photothermal synergistic therapy. Chem Eng J, 2017, 312: 144–15710.1016/j.cej.2016.11.122 ↗
35. Huang Q, Lin X, Zhu JJ, et al. Pd-Au@carbon dots nanocomposite: Facile synthesis and application as an ultrasensitive electrochemical biosensor for determination of colitoxin DNA in human serum. Biosens Bioelectron, 2017, 94: 507–51210.1016/j.bios.2017.03.048 ↗
36. Gao N, Yang W, Nie H, et al. Turn-on theranostic fluorescent nanoprobe by electrostatic self-assembly of carbon dots with doxorubicin for targeted cancer cell imaging, in vivo hyaluronidase analysis, and targeted drug delivery. Biosens Bioelectron, 2017, 96: 300–30710.1016/j.bios.2017.05.019 ↗
37. Ge J, Lan M, Liu W, et al. Graphene quantum dots as efficient, metal-free, visible-light-active photocatalysts. Sci China Mater, 2016, 59: 12–1910.1007/s40843-016-0115-0 ↗
38. Wang Z, Yuan F, Li X, et al. 53% Efficient red emissive carbon quantum dots for high color rendering and stable warm whitelight-emitting diodes. Adv Mater, 2017, 29: 170291010.1002/adma.201702910 ↗
39. Ong WJ, Putri LK, Tan YC, et al. Unravelling charge carrier dynamics in protonated g-C3N4 interfaced with carbon nanodots as co-catalysts toward enhanced photocatalytic CO2 reduction: A combined experimental and first-principles DFT study. Nano Res, 2017, 10: 1673–169610.1007/s12274-016-1391-4 ↗
40. Huang P, Lin J, Wang X, et al. Light-triggered theranostics based on photosensitizer-conjugated carbon dots for simultaneous enhanced-fluorescence imaging and photodynamic therapy. Adv Mater, 2012, 24: 5104–511010.1002/adma.201200650 ↗
41. Choi Y, Kim S, Choi MH, et al. Highly biocompatible carbon nanodots for simultaneous bioimaging and targeted photodynamic therapy in vitro and in vivo. Adv Funct Mater, 2014, 24: 5781–578910.1002/adfm.201400961 ↗
42. Zheng M, Liu S, Li J, et al. Integrating oxaliplatin with highly luminescent carbon dots: an unprecedented theranostic agent for personalized medicine. Adv Mater, 2014, 26: 3554–356010.1002/adma.201306192 ↗
43. Karthik S, Saha B, Ghosh SK, et al. Photoresponsive quinoline tethered fluorescent carbon dots for regulated anticancer drug delivery. Chem Commun, 2013, 49: 10471–1047310.1039/c3cc46078a ↗
44. Zhang M, Wang W, Zhou N, et al. Near-infrared light triggered photo-therapy, in combination with chemotherapy using magnetofluorescent carbon quantum dots for effective cancer treating. Carbon, 2017, 118: 752–76410.1016/j.carbon.2017.03.085 ↗
45. Fan Z, Zhou S, Garcia C, et al. pH-responsive fluorescent graphene quantum dots for fluorescence-guided cancer surgery and diagnosis. Nanoscale, 2017, 9: 4928–493310.1039/C7NR00888K ↗
46. Zheng DW, Li B, Li CX, et al. Carbon-dot-decorated carbon nitride nanoparticles for enhanced photodynamic therapy against hypoxic tumor via water splitting. ACS Nano, 2016, 10: 8715–872210.1021/acsnano.6b04156 ↗
47. Zeng Q, Shao D, He X, et al. Carbon dots as a trackable drug delivery carrier for localized cancer therapy in vivo. J Mater Chem B, 2016, 4: 5119–512610.1039/C6TB01259K ↗
48. Feng T, Ai X, An G, et al. Charge-convertible carbon dots for imaging-guided drug delivery with enhanced in vivo cancer therapeutic efficiency. ACS Nano, 2016, 10: 4410–442010.1021/acsnano.6b00043 ↗
49. Ge J, Lan M, Zhou B, et al. A graphene quantum dot photodynamic therapy agent with high singlet oxygen generation. Nat Commun, 2014, 5: 459610.1038/ncomms5596 ↗
50. Ge J, Jia Q, Liu W, et al. Carbon dots with intrinsic theranostic properties for bioimaging, red-light-triggered photodynamic/photothermal simultaneous therapy in vitro and in vivo. Adv Healthcare Mater, 2016, 5: 665–67510.1002/adhm.201500720 ↗
51. Ge J, Jia Q, Liu W, et al. Red-emissive carbon dots for fluorescent, photoacoustic, and thermal theranostics in living mice. Adv Mater, 2015, 27: 4169–417710.1002/adma.201500323 ↗
52. Cai QY, Li J, Ge J, et al. A rapid fluorescence “switch-on” assay for glutathione detection by using carbon dots–MnO2 nanocomposites. Biosens Bioelectron, 2015, 72: 31–3610.1016/j.bios.2015.04.077 ↗
53. Zhu W, Dong Z, Fu T, et al. Modulation of hypoxia in solid tumor microenvironment with MnO2 nanoparticles to enhance photodynamic therapy. Adv Funct Mater, 2016, 26: 5490–549810.1002/adfm.201600676 ↗
54. Chen Y, Ye D, Wu M, et al. Break-up of two-dimensional MnO2 nanosheets promotes ultrasensitive pH-triggered theranostics of cancer. Adv Mater, 2014, 26: 7019–702610.1002/adma.201402572 ↗
55. Prasad P, Gordijo CR, Abbasi AZ, et al. Correction to multifunctional albumin–MnO2 nanoparticles modulate solid tumor microenvironment by attenuating hypoxia, acidosis, vascular endothelial growth factor and enhance radiation response. ACS Nano, 2014, 8: 6510–651010.1021/nn502569e ↗
56. Abbasi AZ, Gordijo CR, Amini MA, et al. Hybrid manganese dioxide nanoparticles potentiate radiation therapy by modulating tumor hypoxia. Cancer Res, 2016, 76: 6643–665610.1158/0008-5472.CAN-15-3475 ↗
57. Song M, Liu T, Shi C, et al. Bioconjugated manganese dioxide nanoparticles enhance chemotherapy response by priming tumorassociated macrophages toward m1-like phenotype and attenuating tumor hypoxia. ACS Nano, 2016, 10: 633–64710.1021/acsnano.5b06779 ↗
58. Fan W, Bu W, Shen B, et al. Intelligent MnO2 nanosheets anchored with upconversion nanoprobes for concurrent pH-/H2O2-responsive UCL imaging and oxygen-elevated synergetic therapy. Adv Mater, 2015, 27: 4155–416110.1002/adma.201405141 ↗
59. Yang G, Xu L, Chao Y, et al. Hollow MnO2 as a tumor-microenvironment-responsive biodegradable nano-platform for combination therapy favoring antitumor immune responses. Nat Commun, 2017, 8: 90210.1038/s41467-017-01050-0 ↗
60. Gao S, Wang G, Qin Z, et al. Oxygen-generating hybrid nanoparticles to enhance fluorescent/photoacoustic/ultrasound imaging guided tumor photodynamic therapy. Biomaterials, 2017, 112: 324–33510.1016/j.biomaterials.2016.10.030 ↗
61. Fang J, Nakamura H, Maeda H. The EPR effect: unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect. Adv Drug Deliver Rev, 2011, 63: 136–15110.1016/j.addr.2010.04.009 ↗
62. Peng J, Dong M, Ran B, et al. “One-for-all”-type, biodegradable prussian blue/manganese dioxide hybrid nanocrystal for trimodal imaging-guided photothermal therapy and oxygen regulation of breast cancer. ACS Appl Mater Interfaces, 2017, 9: 13875–1388610.1021/acsami.7b01365 ↗